Mariana N. Nikiforova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Molecular testing for mutations activating the mitogen-associated protein kinase signaling pathway is being used to help diagnose thyroid carcinomas. However, the prevalence of these mutations in thyroid lymphomas has not been reported. Therefore, we studied the prevalence of BRAF, NRAS, HRAS, and KRAS mutations in 33 thyroid lymphomas and correlated the(More)
  • 1